Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

BioAtla (BCAB) Shares Issued (2020 - 2025)

BioAtla (BCAB) has disclosed Shares Issued for 6 consecutive years, with $53000.0 as the latest value for Q4 2025.

  • For Q4 2025, Shares Issued fell 45.92% year-over-year to $53000.0; the TTM value through Dec 2025 reached $151000.0, down 42.15%, while the annual FY2025 figure was $100000.0, 70.76% down from the prior year.
  • Shares Issued hit $53000.0 in Q4 2025 for BioAtla, down from $98000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $70.8 million in Q4 2021 and bottomed at -$1.9 million in Q1 2021.
  • Average Shares Issued over 5 years is $16.6 million, with a median of $123500.0 recorded in 2023.
  • Year-over-year, Shares Issued fell 12.91% in 2022 and then plummeted 99.76% in 2023.
  • BioAtla's Shares Issued stood at $70.8 million in 2021, then decreased by 12.91% to $61.7 million in 2022, then tumbled by 99.76% to $149000.0 in 2023, then crashed by 34.23% to $98000.0 in 2024, then crashed by 45.92% to $53000.0 in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $53000.0, $98000.0, and $149000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.